Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?

Minimal Residual Disease Prior to and After Haematopoietic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia: What Level of Negativity Is Relevant?

Minimal residual disease (MRD) assessment plays a central role in risk stratification and treatment guidance in paediatric patients with acute lymphoblastic leukaemia (ALL). As such, MRD prior to haematopoietic stem cell transplantation (HSCT) is a major factor that is independently correlated with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pietro Merli, Marianne Ifversen, Tony H. Truong, Hanne V. Marquart, Jochen Buechner, Matthias Wölfl, Peter Bader
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
minimal residual disease (MRD)
acute lymphoblastic leukaemia (ALL)
haematopoietic stem cell transplantation (HSCT)
children
relapse
Pediatrics
RJ1-570
Acceso en línea:https://doaj.org/article/e0a0937ef4b44e059d9150d003ca4ae9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares